Quick Read Azure grew 43%, the commercial backlog surged 84% to $678B, yet MSFT trades at just 28x earnings, making it a rare setup for patient buyers. MSFT gained just 4% year to date versus QQQ's 22%, with rising rates, runaway AI capex, and investor rotation all compressing its multiple. October earnings are the trigger. Azure at or above 45% growth reclaims $500, while a miss on either Azure or the $175B capex plan sends shares to $475. Just released. Our analysts combed the entire stock market and named the ten best stocks to buy right now, and Microsoft didn't make the cut. Enter your email to see the names that beat MSFT. The report is free. Enter your email and see if any of your stocks made the cut.
Mostramos la idea principal publicamente. Crea una cuenta gratis para seguir leyendo el articulo completo, guardarlo, comentarlo y conectarlo con contexto de mercados y OSINT.